Syphilis

Syphilis is a sexually transmitted disease caused by the spirochetal bacteria Treponema pallidum subspecies pallidum. The primary route of transmission of syphilis is through sexual contact however...

Regulatory Update -- Stiefel, a GSK company announces a new, alternate, fixed-dose combination of Duac® (clindamycin 1% and benzoyl peroxide 3%) gains positive recommendation for approval in Europe

RESEARCH TRIANGLE PARK, North Carolina, March 4, 2013 /PRNewswire/ -- Stiefel, a GSK (LSE:GSK) company, announced today that it has received positive recommendation by MHRA (Medicine and Healthcar...

Regulatorische Aktualisierung -- Stiefel, ein Unternehmen von GSK, gab bekannt, dass neue, alternative Fixkombination von Duac® (1 % Clindamycin und 3 % Benzoylperoxidin) eine positive Empfehlung zur Zulassung in Europa erhalten hat

Research Triangle Park, North Carolina (ots/PRNewswire) - Stiefel, ein Unternehmen von GSK , gab heute bekannt, dass das Unternehmen eine positive Empfehlung von der medizinischen Zulassungs- und A...

BRIEF-Stiefel announces new dosage for Duac

LONDON, March 4 (Reuters) - Stiefel: * Stiefel announces a new, alternate, fixed-dose combination of duac gains

Welichem and Stiefel, a GSK company, complete the acquisition by Stiefel of the novel anti-inflammatory agent, WBI-1001

VANCOUVER, July 31, 2012 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company" TSX.V: WBI) announces that Welichem and Stiefel, a GSK company, have completed the acquisition by Stiefel of the exc...

GSK’s Stiefel Adds Psoriasis/Atopical Dermatitis Candidate In Licensing Deal

For about $34 million, Stiefel gets development and commercialization rights in most of the world to a novel, non-steroidal, topical anti-inflammatory compound in Phase II.

Stiefel, Basilea sign agreement for Toctino

Basilea Pharmaceutical has signed a global agreement with Stiefel , a GSK company, for Toctino (alitretinoin).

Stiefel acquires most global rights to Welichem's novel topical NSAID

Skin care specialist Stiefel, a GlaxoSmithKline company, has paid $35 million up front to acquire WBI-1001, a novel anti-inflammatory agent to treat psoriasis and atopic dermatitis, from Welichem Bi...

Basilea, Stiefel complete dermatology drug transaction

Basilea Pharmaceutica and Stiefel have completed the transaction of Basilea's dermatology drug,Toctino (alitretinoin) following the antitrust approval and other customary provisions.

In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.

The triazole antifungal pramiconazole (Stiefel, a GSK company) was compared with itraconazole, miconazole and terbinafine in vitro and in vivo. A potent in vitro activity against Candida spp. (IC50 0....

Vascular injury following accidental intra-arterial injection of clindamycin: adverse drug reaction report.

Clindamycin in a commonly used antibiotic, considered safe for oral, intravenous and intra-arterial use. We present a case of a patient that received an inadvertent injection clindamycin 600 mg in 4 m...

Quantum mechanical studies of lincosamides.

Lincosamides are a class of antibiotics used both in clinical and veterinary practice for a wide range of pathogens. This group of drugs inhibits the activity of the bacterial ribosome by binding to t...

Comparison of the Effects of Human β-defensin 3, Vancomycin, and Clindamycin on Staphylococcus aureus Biofilm Formation.

Despite improvements in surgical techniques and implant design in orthopedic surgery, implantation-associated infections are still a challenging problem for surgeons. In 2006, trace quantities of huma...

Genome-scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites.

Here, we fully characterize the genomes of 14 Plasmodium falciparum patient isolates taken recently from the Iquitos region using genome scanning, a microarray-based technique that delineates the majo...